Pyrimidine nucleotides suppress KDRcurrents and depolarize rat cerebral arteries by activating Rho kinase
Authors:
- Suzanne E. BrettSBSuzanne E. Brett
- Bin Nan WuBWBin Nan Wu
- William B. WiehlerWWWilliam B. Wiehler
- Donald G. WelshDWDonald G. Welsh
- 1 March 2004
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 286 (3) , H1088-H1100
Abstract
This study examined whether, and by what signaling and ionic mechanisms, pyrimidine nucleotides constrict rat cerebral arteries. Cannulated cerebral arteries stripped of endothelium and pressurized to 15 mmHg constricted in a dose-dependent manner to UTP. This constriction was partly dependent on the depolarization of smooth muscle cells and the activation of voltage-operated Ca2+channels. The depolarization and constriction induced by UTP were unaffected by bisindolylmaleimide I, a PKC inhibitor that abolished phorbol ester (PMA)-induced constriction in cerebral arteries. In contrast, the Rhokinase inhibitor Y-27632 attenuated the ability of UTP to both constrict and depolarize cerebral arteries. With patch-clamp electrophysiology, a voltage-dependent delayed rectifying K+(KDR) current was isolated and shown to consist of a slowly inactivating 4-aminopyridine (4-AP)-sensitive and an -insensitive component. The 4-AP-sensitive KDRcurrent was potently suppressed by UTP through a mechanism that was not dependent on PKC. This reflects observations that demonstrated that 1) a PKC activator (PMA) had no effect on KDRand 2) PKC inhibitors (calphostin C or bisindolylmaleimide I) could not prevent the suppression of KDRby UTP. The Rho kinase inhibitor Y-27632 abolished the ability of UTP to inhibit the KDRcurrent, as did inhibition of RhoA with C3 exoenzyme. Cumulatively, these observations indicate that Rho kinase signaling plays an important role in eliciting the cerebral constriction induced by pyrimidine nucleotides. Moreover, they demonstrate for the first time that Rhokinase partly mediates this constriction by altering ion channels that control membrane potential and Ca2+influx through voltage-operated Ca2+channels.Keywords
This publication has 39 references indexed in Scilit:
- Thromboxane A 2 -Induced Inhibition of Voltage-Gated K + Channels and Pulmonary VasoconstrictionCirculation Research, 2003
- Molecular Variants of KCNQ Channels Expressed in Murine Portal Vein MyocytesCirculation Research, 2003
- Swelling‐activated cation channels mediate depolarization of rat cerebrovascular smooth muscle by hyposmolarity and intravascular pressureThe Journal of Physiology, 2000
- Signal transduction by G‐proteins, Rho‐kinase and protein phosphatase to smooth muscle and non‐muscle myosin IIThe Journal of Physiology, 2000
- Functional Hyperemia in the BrainStroke, 1998
- Vasoconstrictors inhibit ATP-sensitive K+ channels in arterial smooth muscle through protein kinase C.Journal of General Physiology, 1996
- Regulation of 4-aminopyridine-sensitive, delayed rectifier K+ channels in vascular smooth muscle by phosphorylationBiochemistry and Cell Biology, 1996
- Ca2+ currents in cerebral artery smooth muscle cells of rat at physiological Ca2+ concentrations.Journal of General Physiology, 1996
- Uptake and Flow-induced Release of Uridine Nucleotides from Isolated Vascular Endothelial CellsEndothelium, 1995
- Effects of ATP and UTP on [Ca2+]i, Membrane Potential and Force in Isolated Rat Small ArteriesJournal of Vascular Research, 1992